Global COVID-19 Antigen Kit Market Growth 2023-2029

Global COVID-19 Antigen Kit Market Growth 2023-2029

COVID-19 Antigen Kit are rapid antigen tests used to detect COVID-19 infection.

LPI (LP Information)' newest research report, the “COVID-19 Antigen Kit Industry Forecast” looks at past sales and reviews total world COVID-19 Antigen Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected COVID-19 Antigen Kit sales for 2023 through 2029. With COVID-19 Antigen Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 Antigen Kit industry.

This Insight Report provides a comprehensive analysis of the global COVID-19 Antigen Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COVID-19 Antigen Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global COVID-19 Antigen Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 Antigen Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 Antigen Kit.

The global COVID-19 Antigen Kit market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for COVID-19 Antigen Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for COVID-19 Antigen Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for COVID-19 Antigen Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key COVID-19 Antigen Kit players cover Assay Genie, Arista Biotech, Becton, Ellume, iHealth Lab, Quest Diagnostics, Abbott, Quidel and BioFire Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Antigen Kit market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Rapid Detection Kit
PCR Kit

Segmentation by application
Domestic Use
Clinic
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Assay Genie
Arista Biotech
Becton
Ellume
iHealth Lab
Quest Diagnostics
Abbott
Quidel
BioFire Diagnostics
BGI Genomics
BioMedomics
Cepheid
Chembio Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global COVID-19 Antigen Kit market?

What factors are driving COVID-19 Antigen Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do COVID-19 Antigen Kit market opportunities vary by end market size?

How does COVID-19 Antigen Kit break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.